PRODUCT ADMINISTERED IN INAPPROPRIATE SETTING

PRODUCT ADMINISTERED IN INAPPROPRIATE SETTING was reported 5 times

PRODUCT ADMINISTERED IN INAPPROPRIATE SETTING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FEZOLINETANT 1 0.0004
1 HYDROXOCOBALAMIN 1 0.0002
2 BETAMETHASONE VALERATE FOAM 1 0.0002
3 BOTULINUM TOXIN TYPE A 1 0.0001
4 SUMATRIPTAN SUCCINATE 1 0.0000
5 SUMATRIPTAN 1 0.0000
6 MEPOLIZUMAB 1 0.0000
7 RITUXIMAB 1 0.0000
8 INFLIXIMAB 1 0.0000